Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

717-circulating-and-tissue-biomarkers-in-early-stage-non-small-cell-lung-cancer

Research: Circulating and tissue biomarkers in early-stage non-small cell lung cancer

Caterina Fumagalli, Fabrizio Bianchi, Paola Rafaniello Raviele, Davide Vacirca, Giovanni Bertalot, Cristiano Rampinelli, Matteo Lazzeroni, Bernardo Bonnani, Giulia Veronesi, Nicola Fusco, Massimo Barberis, Elena Guerini-Rocco

31 Jan 2017

https://doi.org/10.3332/ecancer.2017.717

Abstract | Full Article | PDF

703-biomarkers-come-of-age-pd1-in-the-frontline-and-cell-cycle-therapy-swells-the-ranks-of-personalised-therapy-in-the-european-society-of-medical-oncology-esmo-congress-copenhagen-7-10-october-2016

Conference Report: Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Will Davies

16 Dec 2016

https://doi.org/10.3332/ecancer.2016.703

Abstract | Full Article | PDF

691-cancer-immunotherapy-from-the-lab-to-clinical-applications-potential-impact-on-cancer-centres-organisation

Conference Report: Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

Linda Cairns, Sandrine Aspeslagh, Andrea Anichini, Jon Amund Kyte, Christian Blank, Paolo Ascierto, Nicolle Rekers, Per Thor Straten, Ahmad Awada

9 Nov 2016

https://doi.org/10.3332/ecancer.2016.691

Abstract | Full Article | PDF

677-veror-radiotherapy-for-low-burden-cancer-789-patients-with-957-lesions

Research: VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

R Orecchia, A Surgo, M Muto, A Ferrari, G Piperno, MA Gerardi, S Comi, C Garibaldi, D Ciardo, A Bazani, F Golino, F Pansini, C Fodor, P Romanelli, D Maestri, V Scroffi, S Mazza, BA Jereczek-Fossa

29 Sep 2016

https://doi.org/10.3332/ecancer.2016.677

Abstract | Full Article | PDF

670-maps-and-atlases-of-cancer-mortality-a-review-of-a-useful-tool-to-trigger-new-questions

Review: Maps and atlases of cancer mortality: a review of a useful tool to trigger new questions

Alberto d'Onofrio, Chiara Mazzetta, Chris Robertson, Michel Smans, Peter Boyle, Mathieu Boniol

1 Sep 2016

https://doi.org/10.3332/ecancer.2016.670

Abstract | Full Article | PDF

669-highlights-from-the-2016-win-symposium-27-29-june-2016-paris-personalised-therapy-beyond-next-generation-sequencing

Conference Report: Highlights from the 2016 WIN Symposium, 27–29 June 2016, Paris: personalised therapy beyond next-generation sequencing

Richard Schilsky, Will Davies

24 Aug 2016

https://doi.org/10.3332/ecancer.2016.669

Abstract | Full Article | PDF

658-highlights-from-the-first-international-ecancer-conference-on-oncology-and-radiotherapy-6-7-may-2016-santiago-chile

Conference Report: Highlights from the first International ecancer Conference on Oncology and Radiotherapy, 6–7 May 2016, Santiago, Chile

Leonardo Carmona Reimann, Beatriz Amendola

22 Jul 2016

https://doi.org/10.3332/ecancer.2016.658

Abstract | Full Article | PDF | Spanish

648-targeted-therapies-and-immunotherapy-in-non-small-cell-lung-cancer

Review: Targeted therapies and immunotherapy in non-small-cell lung cancer

D Cortinovis, M Abbate, P Bidoli, S Capici, S Canova

23 Jun 2016

https://doi.org/10.3332/ecancer.2016.648

Abstract | Full Article | PDF

638-the-steady-progress-of-targeted-therapies-promising-advances-for-lung-cancer

Review: The steady progress of targeted therapies, promising advances for lung cancer

Lorenzo Bombardelli, Anton Berns

28 Apr 2016

https://doi.org/10.3332/ecancer.2016.638

Abstract | Full Article | PDF

Special Issue: Molecular profile of liquid biopsies: next generation biomarkers to improve lung cancer treatment

Fabrizio Bianchi

24 Nov 2015

https://doi.org/10.3332/ecancer.2015.598

Abstract | Full Article | PDF

More from ecancer